ADHC is a holding company that provides executive management, corporate governance, administrative support, financial advice, and introductions to capital sources to various micro-cap private and public companies that have proven revenues and business models.

Average daily volume for ADHC is 2 million shares. Today’s news has caused the volume to spike over 19 million shares in the morning hours of trading.

American Diversified Holdings Corp.Press Release:

ADHC Files Current Year End Financials Valuing AURACISTMMigraine Bio-Device Patents In Excess of $500,000

DEL MAR, CA / ACCESSWIRE / October 16, 2018 / American Diversified Holdings Corporation (OTC PINK: ADHC) has filed its current year end financials which can be found under the ticker symbol ADHC at

After closely following the Cannabis markets ADHC management has determined the timing is appropriate for entering this sector and has formed an operating business which will be the vehicle for managing business initiatives. The company will be offering a selection of life style products in the legal cannabis market as our first initiatives in the Cannabis sector.

The impetus to fully enter the Cannabis space is based upon several events have occurred; including full legalization in Canada on October 17th, Relaxation of federal rules on CBD, Major investments by multi-national beverage companies in the infused beverage arena and numerous analyst reports indicating the US Cannabis market to grow to over $200 billion in the next decade.

American Cannabis Holdings Inc. will be initially focused on Direct to Consumer markets primarilyin infused beverages, Medical Cannabis and will continue to monitor the US federal policy for additional market opportunities.

Management is in late stage negotiations with Cannabis industry partners and will be updating shareholders in the near term.

In additional news ADHC has filed its’ current year end financials. Brazos Biomedical, Inc. and its patented technology AURACISTM migraine management device are progressing along its development path.

“The Auracis international patent portfolio includes two issued US patents and international counterparts. The patent portfolio covers the head-worn, electrode-containing device to be used for pain from migraine headaches,” commented ADHC management.

ADHC recently filed financials value the patent portfolio in excess of $500,000. Recent reports indicate that the US migraine surpasses $55 billion in treating over 38 million people suffering from migraines.

The AURACISTM TENS (transcutaneous electric nerve stimulation) migraine device was derived from the OMEGA surgical procedure, where electrodes are implanted in the cranium under the skin blocking nerve impulses. Management believes a less invasive non-surgical non-opioid head worn TENS device will provide relief for the millions of patients that do not qualify for a surgical procedure or are looking for an alternative to traditional medications.

Investors can find a complete overview of all the AURACIS information on the website.

ADHC is a holding company that provides executive management, corporate governance, administrative support, financial advice, and introductions to capital sources to various micro-cap private and public companies that have proven revenues and business models.

BRAZOS BIOMEDICAL LLC is a bio device company utilizing electro stimulation for pain management to improve patient outcomes through creative innovation with a core competency in the migraine and headache pain space.

This press release contains forward-looking statements pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements include risks and uncertainties that may cause the Company’s plans to change and are in no way intended to guarantee that the Company will be successful in executing its plans. common stock currently trades on the over-the-counter under the symbol ADHC. This press release in no way constitutes any recommendation regarding the securities of ADHC or its affiliates. Any person reading this press release is advised that this release should be considered in the light of all facts and circumstances regarding the business and financial condition and prospects of ADHC, and no reference has been made that this release contains all information.

Contact: Tel: 858-259-4534

About is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks., or its associates may have a position either long or short in any company mentioned herein. Please read our full disclosure, which can be found here, Please consult an investment professional before investing in anything viewed within this article or any other portion of In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the website.

Add a Comment to this Post